Is Noramco, LLC FDA approved?

Noramco, LLC holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

What drugs does Noramco, LLC make?

15 products are listed under Noramco, LLC in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Noramco, LLC

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 15
Live patents: 0
Countries: 1
Base: United States

Authorisation

Registered operations

Active ingredient (API) manufacture1particle size reduction1Repackaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Noramco, LLC	500 Swedes Landing Road, Wilmington, Delaware (DE) 19801, United States (USA)	Active ingredient (API) manufacture, particle size reduction, Repackaging	2522445166506142

Catalogue

Drug listings by form and route

15 active NDC listings: 15 bulk ingredient. By marketing category: BULK INGREDIENT 15.

Dosage form	NDCs
powder	15

Route	NDCs

Labeller name on the listing	NDCs
noramco, llc	15

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
-	Buprenorphine	powder	51634-1039BULK INGREDIENT
-	Buprenorphine Hydrochloride	powder	51634-0608BULK INGREDIENT
-	Codeine Phosphate	powder	51634-0999BULK INGREDIENT
-	Hydrocodone Bitartrate	powder	51634-0014BULK INGREDIENT
-	Hydromorphone Hydrochloride	powder	51634-0057BULK INGREDIENT
-	Lisdexamfetamine Dimesylate	powder	51634-2058BULK INGREDIENT
-	Methylnaltrexone Bromide	powder	51634-3248BULK INGREDIENT
-	Methylphenidate Hydrochloride	powder	51634-0114BULK INGREDIENT
-	Morphine Sulfate	powder	51634-0969BULK INGREDIENT
-	Naloxone Hydrochloride Dihydrate	powder	51634-2018BULK INGREDIENT
-	Naltrexone Base	powder	51634-1060BULK INGREDIENT
-	Naltrexone Hydrochloride	powder	51634-1064BULK INGREDIENT
-	Oxycodone Hydrochloride	powder	51634-0002BULK INGREDIENT
-	Oxymorphone Hydrochloride	powder	51634-0095BULK INGREDIENT
-	Purified Oxycodone Base	powder	51634-0003BULK INGREDIENT

Compare

Comparable companies in United States

NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
Golden State Medical Supply Inc.1 site · 670 NDC
Rising Pharma Holdings, Inc.1 site · 532 NDC
HF Acquisition Co LLC1 site · 363 NDC
ANI Pharmaceuticals, Inc.1 site · 299 NDC
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
Lannett Company, LLC1 site · 190 NDC
OHM PHARMA INC.1 site · 155 NDC
CHATTEM, INC.1 site · 153 NDC

Enquiry

Common questions

Is Noramco, LLC FDA approved?: Noramco, LLC holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Noramco, LLC's drugs manufactured?: The FDA register lists Wilmington, DE. Registered operations: active ingredient (API) manufacture, particle size reduction, repackaging.
What drugs does Noramco, LLC make?: 15 products are listed under Noramco, LLC in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.